Haemonetics Corp (HAE) |
|
106.95 0.33 (0.31%)
|
10-24 14:28 |
|
Open: |
106.85 |
Pre. Close: |
106.62 |
|
High:
|
107.01 |
Low:
|
105.77 |
|
Volume:
|
343,798 |
Market Cap:
|
5,422M |
|
|
|
|
Haemonetics Corp. engages in the development and distribution of hematology products and solutions. The company is headquartered in Braintree, Massachusetts and currently employs 3,216 full-time employees. The firm provides various products to customers involved in the processing, handling and analysis of blood. The firm's segments include Japan, EMEA, North America Plasma and All Other. Haemonetics provides plasma collection systems and software, which enable plasma fractionators to make pharmaceuticals. The firm enables plasma collection customers to source from it a range of products necessary for plasma collection and storage, including PCS brand plasma collection equipment and disposables, plasma collection containers and intravenous solutions, such as saline. Haemonetics offers automated blood component and manual whole blood collection systems to blood collection centers to collect blood products. The firm offers a range of blood management solutions. The firm has a suite of integrated software solutions, which include solutions for blood drive planning and blood collection. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
107.011 - 107.383 |
107.383 - 107.724 |
|
Low:
|
104.72 - 105.208 |
105.208 - 105.654 |
|
Close:
|
106.18 - 106.857 |
106.857 - 107.477 |
|
Technical analysis |
as of: 2020-10-23 4:44:40 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 125.61 One year: 146.71 |
| Support: |
Support1: 90.61 Support2: 80.14 |
| Resistance: |
Resistance1: 107.54 Resistance2: 125.61 |
| Pivot: |
96.74  |
| Moving Average: |
MA(5): 101.22 MA(20): 94.52
MA(100): 89.37 MA(250): 102.25  |
| MACD: |
MACD(12,26): 3.93 Signal(9): 2.56 |
| Stochastic oscillator: |
%K(14,3): 95.63 %D(3): 85.30 |
| RSI: |
RSI(14): 73.06 |
| 52-week: |
High: 130.75 Low: 63.41 Change(%): -12.9 |
| Average Vol(K): |
3-Month: 52696 10-Days: 47963 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.HAE has closed above the upper band by 0.5%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 40.3% wider than normal. The large width of the bands suggest high volatility as compared to HAE's normal range. The bands have been in this wide range for 0 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Fri, 23 Oct 2020
Haemonetics Co. (NYSE:HAE) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
Thu, 22 Oct 2020
Barrington Research Downgrade Haemonetics Corporation [HAE]. What else is Wall St. saying? - The DBT News
Thu, 22 Oct 2020
Haemonetics Corporation (HAE) Moves 12.13% Higher: These Numbers are Too Good to be True - News Daemon
Thu, 22 Oct 2020
Haemonetics Corporation (HAE): Skating on Thin Ice? We Know the Answer - The News Heater
Wed, 21 Oct 2020
Don’t Let Recent momentum Confuse Your Outlook on Haemonetics Corporation [HAE] - MZP News
Fri, 16 Oct 2020
Bulls Are Starting To Focus In On Haemonetics Corporation (HAE) - Invest Million
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Outperform |
| Return on Equity: |
Neutral |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: Healthcare |
| Industry: Medical Instruments & Supplies |
| Shares Out. (M) |
51 |
| Shares Float (M) |
50 |
|
% Held by Insiders
|
0.87 |
|
% Held by Institutions
|
101.86 |
|
Shares Short (K)
|
1,170 |
|
Shares Short P. Month (K)
|
1,260 |
Stock Financials |
|
EPS
|
1.850 |
|
EPS Est This Year
|
1.610 |
|
EPS Est Next Year
|
1.830 |
|
Book Value (p.s.)
|
12.010 |
|
Profit Margin
|
10.10 |
|
Operating Margin
|
16.00 |
|
Return on Assets (ttm)
|
7.0 |
|
Return on Equity (ttm)
|
15.9 |
|
Qtrly Rev. Growth
|
-18.0 |
|
Gross Profit (p.s.)
|
9.622 |
|
Sales Per Share
|
18.651 |
|
EBITDA (p.s.)
|
4.748 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
167 |
|
Levered Free Cash Flow (M)
|
101 |
Stock Valuations |
|
PE Ratio
|
57.81 |
|
PEG Ratio
|
3.39 |
|
Price to Book value
|
8.91 |
|
Price to Sales
|
5.73 |
|
Price to Cash Flow
|
32.39 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
